BR0111018A - Formulações estáveis lìquidas e sólidas - Google Patents

Formulações estáveis lìquidas e sólidas

Info

Publication number
BR0111018A
BR0111018A BR0111018-7A BR0111018A BR0111018A BR 0111018 A BR0111018 A BR 0111018A BR 0111018 A BR0111018 A BR 0111018A BR 0111018 A BR0111018 A BR 0111018A
Authority
BR
Brazil
Prior art keywords
stable
liquid
stable formulations
solid stable
loratadine
Prior art date
Application number
BR0111018-7A
Other languages
English (en)
Inventor
Sergio Rolando Ulloa Lugo
Jose De Jesus Villacampa Ramos
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2000/005129A external-priority patent/MXPA00005129A/xx
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR0111018A publication Critical patent/BR0111018A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"FORMULAçõES ESTáVEIS LìQUIDAS E SóLIDAS". Composições farmacêuticas estáveis contendo anti-histamínicos não-sedativos tais como loratadina e um descongestionante nasal tal como sulfato de pseudoefedrina e no mínimo um veículo farmaceuticamente aceitável, e composições farmaceuticamente estáveis contendo anti-histamínicos não-sedativos tais como loratadina, descongestionantes nasais tais como pseudoefedrina, e um expectorante tal como Ambroxol e mínimo um veículo farmaceuticamente aceitável os quais são estáveis a degradação química e física e contaminação microbiana.
BR0111018-7A 2000-05-25 2001-05-22 Formulações estáveis lìquidas e sólidas BR0111018A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXPA/A/2000/005129A MXPA00005129A (en) 2000-05-24 Liquid and stable antihistaminic - anti-congestive pharmaceutical compositions
PCT/US2001/016570 WO2001089527A2 (en) 2000-05-24 2001-05-22 Pharmaceutical composition comprising loratadine and a nasal decongestant

Publications (1)

Publication Number Publication Date
BR0111018A true BR0111018A (pt) 2004-02-17

Family

ID=33308448

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111018-7A BR0111018A (pt) 2000-05-25 2001-05-22 Formulações estáveis lìquidas e sólidas

Country Status (7)

Country Link
AU (1) AU2001264806A1 (pt)
BR (1) BR0111018A (pt)
CR (1) CR6804A (pt)
EC (1) ECSP024356A (pt)
PA (1) PA8517201A1 (pt)
PE (1) PE20020055A1 (pt)
WO (1) WO2001089527A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
NZ588134A (en) * 2005-06-17 2010-11-26 Aft Pharmaceuticals Ltd Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion
US20080262017A1 (en) * 2006-06-29 2008-10-23 Ulloa Sergio R Sugar-Free Storage-Stable Antihistaminic Syrups
CN116898799B (zh) * 2023-08-30 2024-04-30 哈尔滨圣泰生物制药有限公司 一种地氯雷他定口服制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
WO1995007103A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
TR199901003T2 (xx) * 1996-10-31 1999-07-21 Schering Corporation Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im.
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤

Also Published As

Publication number Publication date
ECSP024356A (es) 2003-03-31
WO2001089527A3 (en) 2003-10-16
CR6804A (es) 2008-10-29
PE20020055A1 (es) 2002-02-12
WO2001089527A2 (en) 2001-11-29
PA8517201A1 (es) 2002-08-26
AU2001264806A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
BR0212921A (pt) Composição farmacêutica com base em fondant
IT1318539B1 (it) Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
EP1483277A4 (en) CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS OF PREPARATION AND USE, AND FORMULATION AND PHARMACEUTICAL APPLICATIONS
ATE332918T1 (de) Neoglycoproteine
NO20022334D0 (no) Ny sammensetning og anvendelse
ATE513541T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung von calcitonin
IS6263A (is) Lyfjasamsetningar, sem innihalda trípeptíð
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
ATE331529T1 (de) Antigen enthaltende pharmazeutische zusammensetzung
BR0215281A (pt) Compostos de succinimida heterocìclicos fundidos e seus análogos, moduladores da função do receptor de hormÈnio nuclear
TR200100054T2 (tr) Paroksetin metansülfonat
DE60335557D1 (de) Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum
BR0109943A (pt) Composições farmacêuticas
AU2003215245A8 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
DE60019334D1 (de) Antivirale arznei
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
IS7065A (is) Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð
DE69827357D1 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13 E 25 DA LPI

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.